Abstract
Live-attenuated vaccines are the most effective way to establish robust, long-lasting immunity against viruses. However, the possibility of reversion to wild type replication and pathogenicity raises concerns over the safety of these vaccines. The use of host-derived microRNAs (miRNAs) to attenuate viruses has been accomplished in an array of biological contexts. The broad assortment of effective tissue- and species-specific miRNAs, and the ability to target a virus with multiple miRNAs, allow for targeting to be tailored to the virus of interest. While escape is always a concern, effective strategies have been developed to improve the safety and stability of miRNA-attenuated viruses. In this review, we discuss the various approaches that have been used to engineer miRNA-attenuated viruses, the steps that have been taken to improve their safety, and the potential use of these viruses as vaccines.
| Original language | English (US) |
|---|---|
| Article number | 25 |
| Journal | Non-coding RNA |
| Volume | 4 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2 2018 |
Bibliographical note
Publisher Copyright:© 2018 by the authors.
Keywords
- Live-attenuated vaccine
- RNAi
- SiRNA
Fingerprint
Dive into the research topics of 'MicroRNA-Attenuated virus vaccines'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS